296 related articles for article (PubMed ID: 12351423)
1. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats.
Iglesias MA; Ye JM; Frangioudakis G; Saha AK; Tomas E; Ruderman NB; Cooney GJ; Kraegen EW
Diabetes; 2002 Oct; 51(10):2886-94. PubMed ID: 12351423
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside.
Bradley EA; Zhang L; Genders AJ; Richards SM; Rattigan S; Keske MA
Cardiovasc Diabetol; 2015 Jul; 14():91. PubMed ID: 26194188
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
Iglesias MA; Furler SM; Cooney GJ; Kraegen EW; Ye JM
Diabetes; 2004 Jul; 53(7):1649-54. PubMed ID: 15220186
[TBL] [Abstract][Full Text] [Related]
4. Portal venous 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion overcomes hyperinsulinemic suppression of endogenous glucose output.
Camacho RC; Pencek RR; Lacy DB; James FD; Donahue EP; Wasserman DH
Diabetes; 2005 Feb; 54(2):373-82. PubMed ID: 15677495
[TBL] [Abstract][Full Text] [Related]
5. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome.
Buhl ES; Jessen N; Pold R; Ledet T; Flyvbjerg A; Pedersen SB; Pedersen O; Schmitz O; Lund S
Diabetes; 2002 Jul; 51(7):2199-206. PubMed ID: 12086950
[TBL] [Abstract][Full Text] [Related]
6. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.
Buhl ES; Jessen N; Schmitz O; Pedersen SB; Pedersen O; Holman GD; Lund S
Diabetes; 2001 Jan; 50(1):12-7. PubMed ID: 11147776
[TBL] [Abstract][Full Text] [Related]
8. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside renders glucose output by the liver of the dog insensitive to a pharmacological increment in insulin.
Camacho RC; Lacy DB; James FD; Donahue EP; Wasserman DH
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1039-43. PubMed ID: 16046457
[TBL] [Abstract][Full Text] [Related]
10. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
Winder WW; Holmes BF
J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
[TBL] [Abstract][Full Text] [Related]
11. Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside.
Rivas DA; Yaspelkis BB; Hawley JA; Lessard SJ
J Endocrinol; 2009 Sep; 202(3):441-51. PubMed ID: 19574345
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside causes acute hepatic insulin resistance in vivo.
Pencek RR; Shearer J; Camacho RC; James FD; Lacy DB; Fueger PT; Donahue EP; Snead W; Wasserman DH
Diabetes; 2005 Feb; 54(2):355-60. PubMed ID: 15677492
[TBL] [Abstract][Full Text] [Related]
13. Rosiglitazone treatment enhances acute AMP-activated protein kinase-mediated muscle and adipose tissue glucose uptake in high-fat-fed rats.
Ye JM; Dzamko N; Hoy AJ; Iglesias MA; Kemp B; Kraegen E
Diabetes; 2006 Oct; 55(10):2797-804. PubMed ID: 17003345
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
[TBL] [Abstract][Full Text] [Related]
15. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
Suwa M; Nakano H; Radak Z; Kumagai S
Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
[TBL] [Abstract][Full Text] [Related]
16. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous AICAR (5-aminoimidazole-4-carboximide riboside) administration on insulin signaling and resistance in premature baboons, Papio sp.
Blanco CL; Gastaldelli A; Anzueto DG; Winter LA; Seidner SR; McCurnin DC; Liang H; Javors MA; DeFronzo RA; Musi N
PLoS One; 2018; 13(12):e0208757. PubMed ID: 30540820
[TBL] [Abstract][Full Text] [Related]
19. 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.
Cuthbertson DJ; Babraj JA; Mustard KJ; Towler MC; Green KA; Wackerhage H; Leese GP; Baar K; Thomason-Hughes M; Sutherland C; Hardie DG; Rennie MJ
Diabetes; 2007 Aug; 56(8):2078-84. PubMed ID: 17513706
[TBL] [Abstract][Full Text] [Related]
20. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle.
Olsen GS; Hansen BF
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E965-70. PubMed ID: 12376323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
